Pfizer Inc., 10% Owner at Allogene Therapeutics, Inc. (ALLO), bought 22,032,040 shares at $18.00 ($1.0M) on 2018-10-15, disclosed to the SEC on 2018-10-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 21,976,484 | $0 | 0.0% |
| 2 | $18.00 | 55,556 | $1.0M | 100.0% |
| Total | $0.05 avg | 22,032,040 | $1.0M | 100% |
| Filing → |
| SWTX | BUY | 2019-09-19 | $900K | — | Filing → |
| RYTM | BUY | 2017-10-10 | $680K | — | Filing → |
| MIRN | BUY | 2015-10-07 | $5.0M | — | Filing → |